To make a difference in endometriosis we need innovative team science. At Cedars-Sinai, a multidisciplinary team of scientists and physicians have grown a collaborative endometriosis research program comprising epidemiology, genetics, cell biology, pathology, immunology and epigenetics.
The BEME Study
We have developed the Prospective Cohort Study of Biologic and Epidemiologic Markers of Endometriosis (BEME) to evaluate new biomarkers for risk stratification and detection of endometriosis, and to understand disease heterogeneity.
The Biologic and Epidemiologic Markers of Endometriosis (BEME) study was one of the first steps toward building a program of endometriosis research at Cedars-Sinai. We are so grateful to our participants! Patients are eligible to enroll in the BEME study if they are scheduled for a surgery with Cedars-Sinai’s minimally invasive gynecologic surgeons. They are approached by research staff the week prior to the scheduled surgery. Patients scheduled for surgery who do not have endometriosis or are unsure of whether they have endometriosis are also very welcome to participate, as we also have researchers studying fibroids and other gynecologic conditions.
State-of-the-art genomic approaches to understanding an understudied disease
A disease as complex as endometriosis needs innovative and intricate experimental approaches to understand key outstanding questions—how does endometriosis arise? Why is there so much variety in symptoms and outcomes between patients? Can we identify non-invasive ways to detect it? Can we find new ways to treat it? Researchers at Cedars-Sinai continue to adopt the newest emerging genomics methods to unravel the many molecular conundrums of endometriosis and most importantly, find new ways to shorten the time to diagnosis and provide more treatment options for patients.